Stay updated on Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page
- Check6 days agoChange DetectedA notice appears stating that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and linking to related updates and FAQs.SummaryDifference0.7%

- Check13 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check20 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry, v3.7.0, appears in the study record history, replacing the previous v3.6.6. This reflects an update to the record.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry (v3.6.6) was added to the record history and the previous revision (v3.6.5) was removed, representing a small update to the page's version history.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision v3.6.5 has been added to the study's record history, replacing the previous v3.6.4. This update signals a new version of the page in the history log.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.